Staphylococcus aureus in lower respiratory infections: clinical relevance of antimicrobial resistance

P M Shah

doi:10.1053/srin.2001.25625

Staphylococcus aureus in lower respiratory infections: clinical relevance of antimicrobial resistance

Semin Respir Infect. 2001 Sep;16(3):196-202. doi: 10.1053/srin.2001.25625.

Author

P M Shah¹

Affiliation

¹ Klinikum der J.W. Goethe Universitaet, Zentrum der Inneren Medizin, Schwerpunkt Infektiologie, D-60590 Frankfurt am Main, Germany. shah@em.uni-frankfurt.de

PMID: 11562899
DOI: 10.1053/srin.2001.25625

Abstract

Staphylococcus aureus is the most common cause of nosocomial infections and is responsible for many community-acquired infections. Of concern is the increase in resistance to oxacillin (methicillin), with rates as high as 60% in some countries and in some intensive care units. Most of these strains are resistant to other antibacterials. Lately, strains with reduced susceptibility to glycopeptides have been reported.

Publication types

Review

MeSH terms

Community-Acquired Infections / drug therapy
Community-Acquired Infections / microbiology*
Cross Infection / drug therapy
Cross Infection / microbiology*
Humans
Lung Diseases / drug therapy
Lung Diseases / microbiology*
Microbial Sensitivity Tests
Staphylococcal Infections / drug therapy
Staphylococcal Infections / microbiology*
Staphylococcus aureus / drug effects*